Latest News

IKEA dresser topples, kills toddler

About a year after popular furniture manufacturer and retailer IKEA recalled nearly 29 million chests and dressers prone to tipping over, the company reported that a 2-year-old boy was crushed to death by an IKEA Malm dresser. The U.S. Consumer Product Safety Commission (CPSC) informed the company of the accident, which occurred in Buena Park, California in May. Toddler Jozef Dudek was put down for a nap by his father, and was later found under the Malm dresser, the family’s attorney said. An investigation indicates the dresser wasn’t properly attached to the wall. In June 2016, IKEA issued a recall ... Read More

Local woman makes hair loss solutions accessible

Here in Alabama, a Birmingham business has recognized the grave impact that hair loss has on people’s lives and is offering compassion and practical support. People find themselves in need of hair loss solutions such as wigs for a variety of reasons. Some suffer hereditary hair loss, which is associated with aging. Others have the autoimmune disorder, alopecia areata, which can begin in childhood. Many lose hair after undergoing cancer treatments. Some chemotherapy drugs, such as Taxotere, can even cause permanent baldness, leaving cancer survivors visibly facing the effects of their disease for the rest of their lives as they ... Read More

Students test supplements, question safety, efficacy

Davidson College biology professor Mark Barsoum along with 15 Davidson students tested dietary supplements to determine whether they actually contain the ingredients posted on their labels. Dietary supplements are readily available over-the-counter, and millions of Americans consume them every day. The $30-billion supplement industry is only lightly regulated by the Food and Drug Administration (FDA), which oversees prescription and over-the-counter drugs. The agency investigates adverse events related to dietary supplements and conducts laboratory analysis as needed, often finding that many contain hidden drugs or ingredients that pose a health risk to consumers. Other studies have shown that some supplements contain trace amounts ... Read More

Xarelto lags behind aspirin in preventing second stroke

Bayer AG halted a phase 3 study of its blood thinner Xarelto because the drug failed to prove more effective or safer than low-dose aspirin. The Navigate Esus study tested Xarelto for the prevention of strokes and blood clots in patients who had recently had a stroke caused by a blood clot of undetermined source. The trial was stopped upon the recommendation of a third party, which found that the aspirin arms of the study were more effective at preventing strokes caused by blood clots. Furthermore, patients taking Xarelto were more likely to suffer major bleeding compared to those taking ... Read More

Toxic waste removal a priority in wake of California wildfires

Wildfires that swept through Northern California in recent weeks devastated seven counties, including burning more than 100,000 acres of land in Sonoma and Napa counties alone. In the wake of the California fires, residents are facing a massive clean-up effort. One of the more complicated parts of this process involves identifying and disposing of toxic waste. Toxins include industrial and residential products including batteries, paint, electronics, flammable liquids and solvents, and materials that may contain asbestos. State and federal agencies are stepping in to assist. The Press Democrat reports that the U.S. Environmental Protection Agency (EPA) will handle the first ... Read More

New data confirms Invokana amputation risk

In May, after an extensive review of data, the Food and Drug Administration (FDA) ordered Johnson & Johnson’s Janssen Pharmaceuticals to add a black box warning to the labels of its Type 2 diabetes drugs containing the active ingredient canagliflozin to warn against an increased risk of amputations. The warning was added to the brand-name drugs Invokana, Invokamet and Invokamet XR. Since then, the FDA announced that new reports further support the link between canagliflozin and amputation risk. The new data comes from the FDA’s Adverse Event Reporting System (FAERS), which provides an analysis of safety signal reports that were ... Read More

Woman warns about tick related illnesses during fall festivities

It sounded like a perfect fall activity – a visit to the local pumpkin patch. Living in sunny California with temperatures in the 80s and 90s, Jennifer Velasquez donned her usual gear of shorts and flip-flops for the excursion to the field rather than more traditional cool-weather wear. But a few days later she was in misery, covered with a rash, experiencing muscle pain so severe she could barely walk, and losing her hair. A visit to the doctor confirmed she had contracted Rocky Mountain Spotted Fever (RMSF) from a tick bite. She shared her story on her facebook page, ... Read More

Teva launches generic Axiron despite heart risks

Teva Pharmaceuticals Ltd., announced it has launched CII, a generic version of the testosterone replacement therapy Axiron, a topical solution of the prescription medication used to treat adult males with low levels of testosterone due to injury, disease or defect. “We are pleased with the result in the district court, which has helped Teva add yet another product to our industry-leading generic portfolio, providing savings to our customers and to patients,” said Andy Boyer, Teva’s President and CEO, Global Generic Medicines, North America. Axiron is manufactured by Eli Lilly and Co., and has annual sales of about $247 million in ... Read More

Chicago woman accuses nursing home of neglect

A woman is suing Chicago area long-term care facilities for not taking sufficient measures to prevent her now-deceased relative from developing pressure sores, which worsened his overall health, Cook County Record reports. Carrie Kornfeind, independent administrator of the estate of Ronald Kornfeind, filed the lawsuit in Cook County Circuit Court in Illinois against Norwood Crossing assisted living and nursing home, Crystal Pines Rehabilitation and Health Care Center, and associated corporate entities. The lawsuit accuses the health care providers of failing to supervise Ronald Kornfeind which led to his developing pressure ulcers. The lawsuit accuses the nursing home of failing to seek ... Read More

Universal flu shot undergoes world-first human trial

The National Health Service (NHS) has launched the world’s first widespread human testing of an experimental flu vaccine designed to better protect people 65 years and older against influenza. NHS, the public health services of England, Scotland and Wales, hopes to recruit more than 10,000 people aged 65 and older in the study, supported by the National Institute for Health Research and delivered by the University of Oxford in Berkshire and Oxfordshire. If deemed safe and effective, the vaccine could have a major impact no the worldwide fight against influenza, a virus that sickens about a billion people worldwide each ... Read More